Related Experiment Video
Updated: Aug 23, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
Published on: January 5, 2016
Increased frequency of CD27- (naive) B cells and their phenotypic alteration in HIV type 1-infected patients
Yong Chong1, Hideyuki Ikematsu, Masahiro Yamamoto
1Department of General Medicine, Kyushu University, Fukuoka 812-8582, Japan.
Insights
HIV-1 infection increases naive (CD27-) B cells, making them more susceptible to apoptosis. These changes may persist even after effective antiviral therapy, impacting B cell function.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Human Immunodeficiency Virus type 1 (HIV-1) infection is associated with immune dysregulation.
- B cell disorders are recognized complications of HIV-1 infection.
- Peripheral CD27- B cells are considered naive B cells and their role in HIV-1 pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the impact of HIV-1 infection on peripheral CD27- (naive) B cells.
- To analyze phenotypic characteristics and apoptosis susceptibility of CD27- B cells in HIV-1-infected individuals.
- To determine if these alterations persist after highly active antiretroviral therapy (HAART).
Main Methods:
- Flow cytometry was used to analyze peripheral blood samples.
- Quantification of CD27- B cells and their expression of CD38, CD95, and bcl-2.
- Assessment of apoptosis susceptibility using annexin-V binding and cell size measurements.
- Study included drug-naive HIV-1 patients, HAART-treated HIV-1 patients, and uninfected controls.
Main Results:
- HIV-1 infection significantly increases the percentage of CD27- B cells in both drug-naive and HAART-treated patients compared to controls.
- CD27- B cells in drug-naive patients exhibit higher CD38 and CD95 expression and lower bcl-2 expression than controls.
- CD27- B cells in drug-naive patients show increased susceptibility to apoptosis, with some phenotypic alterations potentially persisting after HAART.
Conclusions:
- HIV-1 infection profoundly affects peripheral CD27- (naive) B cells.
- Naive B cells may become activated and highly susceptible to apoptosis during HIV-1 infection.
- Phenotypic changes in naive B cells may persist despite viral load reduction through antiviral therapy.
Abstract:
To investigate HIV-1-related B cell disorders, the quantity of peripheral CD27 negative (CD27-) B cells, their CD38, CD95, and bcl-2 intensities, and their apoptosis susceptibility were examined by flow cytometry analysis in 16 drug-naive patients, 27 HAART-treated patients, and 20 uninfected controls. CD27- B cells have been recognized as naive B cells. The mean percentage of CD27- B cells was significantly higher in drugnaive patients (88.1%) and in HAART-treated patients (83.9%) than in controls (68.6%) (p < 0.01). The intensities of CD38 and CD95 on CD27- B cells were significantly higher in drug-naive patients than in controls (p < 0.01). The intensity of CD95 on CD27- B cells in HAART-treated patients was lower than that of drug-naive patients, but significantly higher than that of controls (p < 0.01). The intensity of bcl-2 on CD27- B cells in drug-naive patients was lower than that of controls. In drug-naive patients, CD27-B cells with high CD38 expression represented low bcl-2 expression. The CD27- B cells of drug-naive patients showed an increased susceptibility to apoptosis, characterized by diminished cell size and a high frequency of annexin-V binding, compared with controls and HAART-treated patients. These findings suggested that HIV-1 infection affects peripheral CD27- (naive) B cells as well as CD27+ (memory) B cells and that CD27- B cells might be activated and rendered highly susceptible to apoptosis by HIV-1 infection. Some phenotypic alterations in CD27- B cells may continue after the reduction of HIV-1 loads by effective antiviral therapy.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

